Max Healthcare

43
Sell
  • Market Cap: Large Cap
  • Industry: Hospital
  • ISIN: INE027H01010
  • NSEID: MAXHEALTH
  • BSEID: 543220
INR
1,094.25
11.6 (1.07%)
BSENSE

Dec 05

BSE+NSE Vol: 12.76 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
5,406.00
4,562.00
3,931.00
2,504.00
1,059.00
1,691.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
5,406.00
4,562.00
3,931.00
2,504.00
1,059.00
1,691.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-14.00
0.00
0.00
0.00
2.00
Raw Materials Consumed
1,119.00
936.00
930.00
580.00
229.00
362.00
Power & Fuel Cost
77.00
69.00
62.00
51.00
22.00
46.00
Employee Cost
934.00
809.00
759.00
588.00
230.00
440.00
Operating Expenses
1,271.00
1,120.00
921.00
631.00
295.00
37.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
66.00
57.00
44.00
16.00
56.00
21.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
69.00
39.00
23.00
39.00
34.00
16.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
3,913.00
3,322.00
2,988.00
2,100.00
965.00
1,535.00
Operating Profit (PBDIT) excl Other Income
1,492.00
1,240.00
942.00
403.00
93.00
155.00
Other Income
178.00
139.00
127.00
114.00
48.00
57.00
Operating Profit (PBDIT)
1,670.00
1,379.00
1,069.00
518.00
141.00
212.00
Interest
59.00
83.00
100.00
179.00
83.00
101.00
Profit before Depriciation and Tax
1,610.00
1,295.00
969.00
339.00
58.00
110.00
Depreciation
244.00
232.00
221.00
174.00
45.00
102.00
Profit Before Taxation & Exceptional Items
1,365.00
1,063.00
747.00
165.00
12.00
8.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,365.00
1,063.00
738.00
-68.00
12.00
8.00
Provision for Tax
307.00
-39.00
133.00
45.00
0.00
8.00
Profit After Tax
1,057.00
1,103.00
605.00
-114.00
12.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,234.00
142.00
-458.00
-324.00
-383.00
-440.00
Profit Available for appropriations
2,291.00
1,245.00
146.00
-462.00
-324.00
-443.00
Appropriations
2,291.00
1,245.00
146.00
-462.00
-324.00
-443.00
Equity Dividend (%)
15.00%
10.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
10.89
11.38
6.25
-1.59
1.01
-0.06
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 13.76% vs 22.93% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 9.36% vs 30.47% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -6.33% vs -0.48% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 2.01% vs -1.02% in Mar 2024

Compare Profit and Loss Results of Max Healthcare
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5,406.00
21,794.00
-16,388.00
-75.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,406.00
21,794.00
-16,388.00
-75.20%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
1,119.00
11,311.00
-10,192.00
-90.11%
Power & Fuel Cost
77.00
266.00
-189.00
-71.05%
Employee Cost
934.00
2,769.00
-1,835.00
-66.27%
Operating Expenses
1,271.00
2,396.00
-1,125.00
-46.95%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
66.00
531.00
-465.00
-87.57%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
69.00
188.00
-119.00
-63.30%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3,913.00
18,772.00
-14,859.00
-79.16%
Operating Profit (PBDIT) excl Other Income
1,492.00
3,021.00
-1,529.00
-50.61%
Other Income
178.00
200.00
-22.00
-11.00%
Operating Profit (PBDIT)
1,670.00
3,222.00
-1,552.00
-48.17%
Interest
59.00
458.00
-399.00
-87.12%
Profit before Depriciation and Tax
1,610.00
2,763.00
-1,153.00
-41.73%
Depreciation
244.00
757.00
-513.00
-67.77%
Profit Before Taxation & Exceptional Items
1,365.00
2,006.00
-641.00
-31.95%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,365.00
2,039.00
-674.00
-33.06%
Provision for Tax
307.00
534.00
-227.00
-42.51%
Profit After Tax
1,057.00
1,472.00
-415.00
-28.19%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,234.00
2,772.00
-1,538.00
-55.48%
Profit Available for appropriations
2,291.00
4,218.00
-1,927.00
-45.69%
Appropriations
2,291.00
4,218.00
-1,927.00
-45.69%
Equity Dividend (%)
15%
253.2%
-238.20
Earnings Per Share
10.89
100.56
-89.67
-89.17%
Profit And Loss - Net Sales
Net Sales 2,663.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.76% vs 22.93% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 833.39 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.36% vs 30.47% in Mar 2024

Profit And Loss - Interest
Interest 48.39 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -6.33% vs -0.48% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 701.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.01% vs -1.02% in Mar 2024